Article
Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.
Journal of genetic counseling - 1 Dec 2017
Shipman Hannah, Flynn Samantha, MacDonald-Smith Carey F, Brenton James, Crawford Robin, Tischkowitz Marc, Hulbert-Williams Nicholas J
Abstract excerpt
Decreasing costs of genetic testing and advances in treatment for women with cancer with germline BRCA1/BRCA2 mutations have heralded more inclusive genetic testing programs. The Genetic Testing in Epithelial Ovarian Cancer (GTEOC) Study, investigates the feasibility and acceptability of offering genetic testing to all women recently diagnosed with epithelial ovarian cancer (universal genetic testing or UGT)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
